Billionaire Ken Griffin’s Top 5 Stock Picks Revealed – Where the Big Money Flows in 2025

Wall Street's whale Ken Griffin just flashed his portfolio hand—here's where the Citadel kingpin is doubling down.

1. The AI Juggernaut He Can't Quit

Griffin's betting big on the silicon brains reshaping markets—no surprise for a guy who built his fortune on algorithmic edge.

2. Cloud Cash Cow

When legacy investors zig toward value, Griffin zags into hyperscalers printing money in the ether.

3. The 'Boring' Backbone Play

Turns out even billionaires need ballast—his third-largest holding keeps the lights on while others chase crypto memes.

4. Pharma's Pandemic Hangover Payday

One firm's post-COVID slump became Griffin's discount buffet. Classic hedge fund move—buy when there's blood in the petri dish.

5. The Stealth Semiconductor Bet

While retail traders fight over GPU stocks, Griffin's quietly cornering the market on chips you've never heard of (but every gadget needs).

The Bottom Line

Griffin's portfolio reads like a playbook for the apocalypse—if that apocalypse involves 10-K filings and stock buybacks. Meanwhile, the rest of us peasants are still trying to time Bitcoin bottoms.

Image source: Getty Images.

The top five

Citadel's technology- and analytics-focused approach to portfolio construction and history of market-crushing performance make the hedge fund's holdings a point of interest for many investors. These are the fund's five biggest stock positions as of the company's most recent public disclosure:

• Charles Schwab (SCHW 0.57%) is a longtime leader in financial services and stands as Citadel's top stock holding. The stock accounted for roughly 1.6% of Citadel's total stock portfolio as of the company's last update.
• Invesco QQQ Trust (QQQ -0.39%) is an exchange traded fund (ETF) that tracks the Nasdaq-100 index and accounted for 1.1% of Citadel's holdings as of the most recent public update.
• Edwards Lifesciences (EW -0.24%) is a medical technology specialist focused on services for patients with heart-valve disease and accounted for 1% of Citadel's stock portfolio weight.
• Medtronic (MDT -0.04%) is a medical company that makes devices used to treat and manage a wide range of health issues, and its stock recently represented roughly 0.8% of Citadel's portfolio holdings.
• Keurig Dr Pepper (KDP 0.52%) is a beverage giant that produces and markets a portfolio of globally known drinks. It recently made up roughly 0.7% of Citadel's stock holdings.

Notably, Hess had been Citadel's second-largest position and accounted for roughly 1.3% of the fund's stock holdings as of the company's last 13F filing, but the energy company was acquired byin July in a $55 billion all-stock deal. If Griffin and Citadel opt to hold on to the Chevron stock received through the buyout, the fund could show a new top-five holding with its next 13F filing.